ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2708

Placental Growth Factor Regulates the Generation of T-Helper 17 Cells to Link Angiogenesis with Autoimmunity

Seung-Ah Yoo Sr.1, Min-cheol Kang Sr.2, Mingyo Kim Sr.3, Jin-Sun Kong Sr.1, Ki-Myo Kim Sr.1, junghee Koh Sr.1, Chul-Soo Cho4, Seung-Hyo Lee Sr.5, Zae Young Ryoo Sr.6 and Wan-Uk Kim Sr.1,7, 1The Catholic University of Korea, Center for Integrative Rheumatoid Transcriptomics and Dynamics, seoul, Korea, Republic of (South), 2School of Life Sciences, BK21 Plus KNU Creative BioResearch Group, Kyungpook National University, seoul, Korea, Republic of (South), 3Graduate School of Medical Science and Engineering, BioMedical Research Center, KAIST Institute for the BioCentury, seoul, Korea, Republic of (South), 4Internal Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South), 5Graduate School of Medical Science and Engineering, BioMedical Research Center, KAIST Institute for the BioCentury, SEOUL, Korea, Republic of (South), 6School of Life Sciences, BK21 Plus KNU Creative BioResearch Group, Kyungpook National University, SEOUL, Korea, Republic of (South), 7The Catholic University of Korea, Department of Internal Medicine, seoul, Korea, Republic of (South)

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: angiogenesis and autoimmune diseases, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: T Cell Biology and Targets in Autoimmune Disease Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: T-helper (Th) cells actively communicate with adjacent cells by secreting soluble mediators, and yet crosstalk between Th cells and endothelial cells is poorly understood. Here, we demonstrated that the placental growth factor (PlGF), an angiogenic factor, was selectively secreted by Th17 cells, and promoted angiogenesis in vitro and in vivo.

Methods: Concentrations of PlGF and interleukin-17 (IL-17) in culture supernatants of stimulated T cells were measured using Enzyme-linked immunosorbent assay (ELISA). The angiogenic effect of PlGF produced by CD4+ T was assessed by measuring the tube formation, wounding migration, and chemotaxis of endothelial cells. Expression of Th17, Treg, and phospho Stat was analyzed by flow cytometry. Experimental Th17 disease model was induced in mice either by immunization with type II collagen (CII) or by injection of MOG35-55 peptide.

Results: : ‘Angio-lymphokin’ PlGF, in turn, specifically induced Th17 cell differentiation and plasticity by activating STAT3 via binding to the FLT1 and NRP1 receptors and substituted for IL6 activity in IL-17 production, whereas it suppressed FOXP3+ Treg cell generation. The disruption of PlGF attenuated the severity of delayed-type hypersensitivity and experimental autoimmune encephalomyelitis in mice by reducing IL-17 production; the adoptive transfer of PlGF-overexpressing CD4+ T cells to these mice restored their disease phenotypes. On the contrary, selective overexpression of PlGF in T cells increased disease severity and IL-17 and STAT3 expressions in mice with autoimmune arthritis. Finally, we observed a correlation between concentrations of PlGF and IL17 in the synovial fluids of rheumatoid arthritis patients.

Conclusion:

Our findings provide novel insights into the PlGF-dictated links between angiogenesis, Th17 cell development, and autoimmunity, indicating that PlGF inhibitors could be used to control autoimmune and inflammatory diseases in hope of dual inhibition of angiogenesis and Th17 cell generation.


Disclosure: S. A. Yoo Sr., the National Research Foundation of Korea, 2; M. C. Kang Sr., None; M. Kim Sr., None; J. S. Kong Sr., None; K. M. Kim Sr., None; J. Koh Sr., None; C. S. Cho, None; S. H. Lee Sr., None; Z. Y. Ryoo Sr., None; W. U. Kim Sr., the National Research Foundation of Korea, 2.

To cite this abstract in AMA style:

Yoo SA Sr., Kang MC Sr., Kim M Sr., Kong JS Sr., Kim KM Sr., Koh J Sr., Cho CS, Lee SH Sr., Ryoo ZY Sr., Kim WU Sr.. Placental Growth Factor Regulates the Generation of T-Helper 17 Cells to Link Angiogenesis with Autoimmunity [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/placental-growth-factor-regulates-the-generation-of-t-helper-17-cells-to-link-angiogenesis-with-autoimmunity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/placental-growth-factor-regulates-the-generation-of-t-helper-17-cells-to-link-angiogenesis-with-autoimmunity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology